142 related articles for article (PubMed ID: 36037830)
21. Prognostic Importance of Temporal Changes in Resting Heart Rate in Heart Failure and Preserved Ejection Fraction: From the TOPCAT Study.
Vazir A; Claggett B; Pitt B; Anand I; Sweitzer N; Fang J; Fleg J; Rouleau J; Shah S; Pfeffer MA; Solomon SD
JACC Heart Fail; 2017 Nov; 5(11):782-791. PubMed ID: 29032132
[TBL] [Abstract][Full Text] [Related]
22. Gender Differences in the Risk of Adverse Outcomes in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction.
O'Neal WT; Sandesara P; Hammadah M; Venkatesh S; Samman-Tahhan A; Kelli HM; Soliman EZ
Am J Cardiol; 2017 Jun; 119(11):1785-1790. PubMed ID: 28395886
[TBL] [Abstract][Full Text] [Related]
23. Risk Stratification and Efficacy of Spironolactone in Patients with Heart Failure with Preserved Ejection Fraction: Secondary Analysis of the TOPCAT Randomized Clinical Trial.
Lin Y; Zhong X; Liu M; Zhang S; Xiong Z; Huang Y; Fan Y; Xu X; Guo Y; Li Y; Sun X; Zhou H; Yang D; Ye X; Liao X; Zhuang X
Cardiovasc Drugs Ther; 2022 Apr; 36(2):323-331. PubMed ID: 33791916
[TBL] [Abstract][Full Text] [Related]
24. Cardiac Troponin I and Risk of Cardiac Events in Patients With Heart Failure and Preserved Ejection Fraction.
Myhre PL; O'Meara E; Claggett BL; de Denus S; Jarolim P; Anand IS; Beldhuis IE; Fleg JL; Lewis E; Pitt B; Rouleau JL; Solomon SD; Pfeffer MA; Desai AS
Circ Heart Fail; 2018 Nov; 11(11):e005312. PubMed ID: 30571192
[TBL] [Abstract][Full Text] [Related]
25. Favorable effects of statins in the treatment of heart failure with preserved ejection fraction in patients without ischemic heart disease.
Tsujimoto T; Kajio H
Int J Cardiol; 2018 Mar; 255():111-117. PubMed ID: 29307549
[TBL] [Abstract][Full Text] [Related]
26. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
[TBL] [Abstract][Full Text] [Related]
27. Role of Ischemic Heart Disease in Major Adverse Renal and Cardiac Events Among Individuals With Heart Failure With Preserved Ejection Fraction (from the TOPCAT Trial).
Rahimi G; Tecson KM; Elsaid O; McCullough PA
Am J Cardiol; 2021 Mar; 142():91-96. PubMed ID: 33279481
[TBL] [Abstract][Full Text] [Related]
28. WATCH-DM risk score predicts the prognosis of diabetic phenotype patients with heart failure and preserved ejection fraction.
Zhang X; Lv X; Wang N; Yu S; Si J; Zhang Y; Cai M; Liu Y
Int J Cardiol; 2023 Aug; 385():34-40. PubMed ID: 37257517
[TBL] [Abstract][Full Text] [Related]
29. Living Alone and Clinical Outcomes in Patients With Heart Failure With Preserved Ejection Fraction.
Zhu W; Wu Y; Zhou Y; Liang W; Xue R; Wu Z; Wu D; He J; Dong Y; Liu C
Psychosom Med; 2021 Jun; 83(5):470-476. PubMed ID: 33901053
[TBL] [Abstract][Full Text] [Related]
30. Sudden Death in Heart Failure With Preserved Ejection Fraction: A Competing Risks Analysis From the TOPCAT Trial.
Vaduganathan M; Claggett BL; Chatterjee NA; Anand IS; Sweitzer NK; Fang JC; O'Meara E; Shah SJ; Hegde SM; Desai AS; Lewis EF; Rouleau J; Pitt B; Pfeffer MA; Solomon SD
JACC Heart Fail; 2018 Aug; 6(8):653-661. PubMed ID: 29501806
[TBL] [Abstract][Full Text] [Related]
31. The Prognostic Significance of Diabetes and Microvascular Complications in Patients With Heart Failure With Preserved Ejection Fraction.
Sandesara PB; O'Neal WT; Kelli HM; Samman-Tahhan A; Hammadah M; Quyyumi AA; Sperling LS
Diabetes Care; 2018 Jan; 41(1):150-155. PubMed ID: 29051160
[TBL] [Abstract][Full Text] [Related]
32. Weight cycling and risk of clinical adverse events in patients with heart failure with preserved ejection fraction: a
Tan Y; Guo H; Zhang N; Zheng K; Liu G
Front Endocrinol (Lausanne); 2023; 14():1159826. PubMed ID: 37234796
[TBL] [Abstract][Full Text] [Related]
33. Diastolic Blood Pressure and Adverse Outcomes in the TOPCAT (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist) Trial.
Sandesara PB; O'Neal WT; Kelli HM; Topel M; Samman-Tahhan A; Sperling LS
J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29475874
[TBL] [Abstract][Full Text] [Related]
34. Sex Differences in Characteristics and Outcomes in Elderly Heart Failure Patients With Preserved Ejection Fraction: A
Sun J; Tai S; Guo Y; Tang L; Yang H; Li X; Xing Z; Fu L; Zhou S
Front Cardiovasc Med; 2021; 8():721850. PubMed ID: 34671652
[No Abstract] [Full Text] [Related]
35. Baseline characteristics of patients in the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial.
Shah SJ; Heitner JF; Sweitzer NK; Anand IS; Kim HY; Harty B; Boineau R; Clausell N; Desai AS; Diaz R; Fleg JL; Gordeev I; Lewis EF; Markov V; O'Meara E; Kobulia B; Shaburishvili T; Solomon SD; Pitt B; Pfeffer MA; Li R
Circ Heart Fail; 2013 Mar; 6(2):184-92. PubMed ID: 23258572
[TBL] [Abstract][Full Text] [Related]
36. Leucocyte count predicts cardiovascular risk in heart failure with preserved ejection fraction: insights from TOPCAT Americas.
Bajaj NS; Kalra R; Gupta K; Aryal S; Rajapreyar I; Lloyd SG; McConathy J; Shah SJ; Prabhu SD
ESC Heart Fail; 2020 Aug; 7(4):1676-1687. PubMed ID: 32424980
[TBL] [Abstract][Full Text] [Related]
37. Body mass index, frailty, and outcomes in heart failure with preserved ejection fraction.
Li W; Wang Z; Hua C; Zhang H; Liu X; Zheng S; Lv Q; Jiang C; Dong J; Ma C; Du X
ESC Heart Fail; 2024 Apr; 11(2):709-718. PubMed ID: 38131256
[TBL] [Abstract][Full Text] [Related]
38. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The TOPCAT Trial.
Cikes M; Claggett B; Shah AM; Desai AS; Lewis EF; Shah SJ; Anand IS; O'Meara E; Rouleau JL; Sweitzer NK; Fang JC; Saksena S; Pitt B; Pfeffer MA; Solomon SD
JACC Heart Fail; 2018 Aug; 6(8):689-697. PubMed ID: 30007557
[TBL] [Abstract][Full Text] [Related]
39. Low diastolic blood pressure and adverse outcomes in heart failure with preserved ejection fraction.
Tsujimoto T; Kajio H
Int J Cardiol; 2018 Jul; 263():69-74. PubMed ID: 29661477
[TBL] [Abstract][Full Text] [Related]
40. Prognostic importance of left ventricular mechanical dyssynchrony in heart failure with preserved ejection fraction.
Biering-Sørensen T; Shah SJ; Anand I; Sweitzer N; Claggett B; Liu L; Pitt B; Pfeffer MA; Solomon SD; Shah AM
Eur J Heart Fail; 2017 Aug; 19(8):1043-1052. PubMed ID: 28322009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
